Cost implications of specific and non-specific treatment for young persons at ultra high risk of developing a first episode of psychosis

Early Interv Psychiatry. 2009 Feb;3(1):28-34. doi: 10.1111/j.1751-7893.2008.00106.x.

Abstract

Aim: Costs associated with mental health treatment for young persons at 'ultra' high risk (UHR) of developing a psychotic disorder have not previously been reported. This paper reports cost implications of providing psychological and pharmacological intervention for individuals at UHR for psychosis compared with minimal psychological treatment.

Method: Mental health service costs associated with a randomized controlled trial of two treatments (Specific Preventive Intervention: SPI and Needs-Based Intervention: NBI) for UHR young persons were estimated and compared at three time points: treatment phase, short-term follow up and medium-term follow up.

Results: Although the SPI group incurred significantly higher treatment costs than the NBI group over the treatment phase, they incurred significantly lower outpatient treatment costs over the longer term.

Conclusion: This study indicates that specific interventions designed to treat young persons who are identified as being at UHR of psychosis might be associated with some cost savings compared with non-specific interventions.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / economics
  • Antipsychotic Agents / therapeutic use
  • Cost Savings / statistics & numerical data
  • Early Diagnosis
  • Female
  • Health Care Costs* / statistics & numerical data
  • Humans
  • Inpatients
  • Male
  • Outpatients
  • Psychotherapy / economics
  • Psychotic Disorders / diagnosis
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / economics*
  • Psychotic Disorders / therapy
  • Risk Factors
  • Young Adult

Substances

  • Antipsychotic Agents